HSKA Financial Facts
Total revenue, net: 33.43MOther vaccines, pharmaceuticals and products: 7.04M
See Full Income Statement
Other current assets: 1.64M
Total current assets: 47.97M
See Full Balance Sheet
Heska Corp. (HSKA) Earnings
|
Expand Research on HSKA
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +37.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/8/23 | Q223 | N/A | $0.40 | N/A | N/A | $70.77M | = | N/A | N/A | ||
| 5/5/23 | Q123 | $0.17 | $0.27 | -$0.10 | $62.38M | $64.2M | = |  | | Details | |
| 2/28/23 | Q422 | $0.55 | $0.20 | +$0.35 | $66.3M | $64.62M | = | | | Details | |
| 11/8/22 | Q322 | $0.41 | $0.37 | +$0.04 | $61.5M | $68.34M |  |
| | Details | |
| 8/8/22 | Q222 | $0.34 | $0.34 | $0.00 | $64.7M | $69.84M | |
| | Details | |
| 5/9/22 |  |
Q122 | $0.27 | -$0.07 | +$0.34 | $64.8M | $66.12M | |
| | Details |
| 2/28/22 | |
Q421 | $0.35 | -$0.03 | +$0.38 | $68.1M | $66.02M | |
| | Details |
| 11/4/21 | |
Q321 | $0.20 | -$0.15 | +$0.35 | $60.2M | $63.8M | = | | | Details |
